National Blood Transfusion Centre of Kosovo Prishtina (NBTCK). Mother Theresa str., 10000 Prishtina, Kosovo.
Bosn J Basic Med Sci. 2009 Nov;9(4):271-7. doi: 10.17305/bjbms.2009.2777.
One of the largest therapeutic problem during the continuous treatment of the patients with Hemophilia A and B, are viral infections as Hepatitis B and C, and HIV, and the other infective diseases, which can be transmitted by the transfusion of blood products. The aim of this study is to analyze the complications of the hemophiliacs in Kosovo which have been treated with fresh frozen plasma, cryoprecipitate and concentrated products of FVIII and FIX. We have tested 75 patients with hemophilia A or B and there were used enzyme immunoassay test-Elisa method for the following: anti-HCV, HBsAg, HIV and TPHA.The serological data showed that HCV infection was positive in 29 cases or 38,7%, whereas infection with HBV and HIV were present in a smaller percentage of the patients (2,7% HBV and 1,4% for HIV). HCV infection was present only in 9,5% of the cases of the age group under 18 years. Infected hemophiliacs with one or two infective agents were found in 34,7%, respectively 4%. Infection with T. pallidum was present at none of the examined patients with hemophilia. HCV infection was higher in severe forms of hemophilia B (44,4%), compared with severe form of hemophilia A (30%).Based on our results, despite the infrequent application of FVIII and FIX concentrates, and other anti hemophilic preparations used in treating hemophilia patients, the number of infected hemophiliacs with blood-transmittable infectious agents was substantially high, especially with hepatitis C virus.
在对甲型和乙型血友病患者进行持续治疗的过程中,最大的治疗问题之一是乙型肝炎和丙型肝炎以及 HIV 等病毒感染以及其他可通过输注血液制品传播的传染病。本研究旨在分析在科索沃用新鲜冷冻血浆、冷沉淀和浓缩的 FVIII 和 FIX 产品治疗的血友病患者的并发症。我们对 75 名甲型或乙型血友病患者进行了检测,采用酶免疫测定法(Elisa 法)检测以下内容:抗 HCV、HBsAg、HIV 和 TPHA。血清学数据显示,29 例(38.7%)丙型肝炎病毒感染呈阳性,而乙型肝炎病毒和 HIV 感染在患者中的比例较小(HBV 为 2.7%,HIV 为 1.4%)。丙型肝炎病毒感染仅见于年龄组 18 岁以下的 9.5%的病例。在 34.7%的患者中发现有一个或两个感染因子的感染血友病患者,分别为 4%。在检查的血友病患者中均未发现梅毒螺旋体感染。乙型血友病(44.4%)严重程度比甲型血友病(30%)更易发生 HCV 感染。基于我们的结果,尽管 FVIII 和 FIX 浓缩物以及用于治疗血友病患者的其他抗血友病制剂的应用频率较低,但患有血液传播传染病的感染血友病患者数量相当高,尤其是丙型肝炎病毒。